{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T03:59:04Z","timestamp":1780631944499,"version":"3.54.1"},"reference-count":15,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2005,2,1]],"date-time":"2005-02-01T00:00:00Z","timestamp":1107216000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Therapeutics"],"published-print":{"date-parts":[[2005,2]]},"DOI":"10.1016\/j.clinthera.2005.02.009","type":"journal-article","created":{"date-parts":[[2005,4,7]],"date-time":"2005-04-07T13:39:46Z","timestamp":1112881186000},"page":"216-224","source":"Crossref","is-referenced-by-count":50,"title":["Topical retinoids in inflammatory acne: A retrospective, investigator-blinded, vehicle-controlled, photographic assessment"],"prefix":"10.1016","volume":"27","author":[{"given":"James J.","family":"Leyden","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan","family":"Shalita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diane","family":"Thiboutot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth","family":"Washenik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guy","family":"Webster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinthera.2005.02.009_bib1","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1001\/archderm.98.1.58","article-title":"Pathogenesis of acne vulgaris. II. Histopathology of comeclones induced in the rabbit ear by human sebum","volume":"98","author":"Kligman","year":"1968","journal-title":"Arch Dermatol"},{"issue":"Suppl 6","key":"10.1016\/j.clinthera.2005.02.009_bib2","first-page":"4","article-title":"Efficacy and tolerability of oncedaily tazarotene 0.1% gel versus once-daily tretinoin 0.025% gel in the treatment of facial acne vulgaris: Arandomized trial","volume":"67","author":"Webster","year":"2001","journal-title":"Cutis"},{"issue":"Suppl 2","key":"10.1016\/j.clinthera.2005.02.009_bib3","first-page":"12","article-title":"Once-daily tazarotene 0.1% gel versus once-daily tretinoin 0.1% microsponge gel for the treatment of facial acne vulgaris: A doubleblind randomizedtrial","volume":"69","author":"Leyden","year":"2002","journal-title":"Cutis"},{"issue":"Suppl 2","key":"10.1016\/j.clinthera.2005.02.009_bib4","first-page":"4","article-title":"A multicenter, double-blind, randomized comparison study of the efficacy and tolerability of oncedaily tazarotene 0.1% gel and adapalene 0.1% gelfor the treatment of facial acne vulgaris","volume":"69","author":"Webster","year":"2002","journal-title":"Cutis"},{"key":"10.1016\/j.clinthera.2005.02.009_bib5","series-title":"Poster presented at: 59th Annual Meeting of the American Academy of Dermatology","article-title":"Comparing the efficacy and tolerability of tazarotene 0.1% gel and tretinoin 0.025% gel in the treatment of facial acne vulgaris: A second multicenter, double-blind, randomized trial","author":"Lowe","year":"2001"},{"key":"10.1016\/j.clinthera.2005.02.009_bib6","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/S0190-9622(96)90443-0","article-title":"A comparison of the efficacy and safety of adapalene gel 0.1% and tretinoin gel 0.025% in the treatment of acne vulgaris: A multicenter trial","volume":"34","author":"Shalita","year":"1996","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clinthera.2005.02.009_bib7","series-title":"Poster presented at: 59th Annual Meeting of the American Academy of Dermatology","article-title":"Tazarotene cream in the treatment of acne","author":"Shalita","year":"2001"},{"issue":"Suppl 6","key":"10.1016\/j.clinthera.2005.02.009_bib8","first-page":"10","article-title":"Comparison of treatment of acne vulgaris with alternate-day applications of tazarotene 0.1% gel and once-daily applications of adapalene 0.1% gel: A randomized trial","volume":"67","author":"Leyden","year":"2001","journal-title":"Cutis"},{"key":"10.1016\/j.clinthera.2005.02.009_bib9","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1001\/archderm.118.1.23","article-title":"Various parameters for grading acne vulgaris","volume":"118","author":"Allen","year":"1982","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.clinthera.2005.02.009_bib10","series-title":"Common Statistical Methods for Clinical Research with SAS Examples","author":"Walker","year":"2002"},{"key":"10.1016\/j.clinthera.2005.02.009_bib11","series-title":"Statistical Power Analysis for the Behavioral Sciences","author":"Cohen","year":"1988"},{"key":"10.1016\/j.clinthera.2005.02.009_bib12","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1007\/BF01964722","article-title":"Arachidonic acid induced ear oedema in four strains of rats and mice: A comparative study of anti-inflammatory drugs","volume":"29","author":"Bouclier","year":"1990","journal-title":"Agents Actions"},{"key":"10.1016\/j.clinthera.2005.02.009_bib13","doi-asserted-by":"crossref","first-page":"S96","DOI":"10.1016\/S0190-9622(97)70050-1","article-title":"Pharmacology and chemistry of adapalene","volume":"36","author":"Shroot","year":"1997","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clinthera.2005.02.009_bib14","series-title":"Poster presented at: 61st Annual Meeting of the American Academy of Dermatology","article-title":"Toll-like receptor-2: A novel mechanism of action of adapalene in the treatment of inflammatory acne lesions","author":"Vega","year":"2003"},{"key":"10.1016\/j.clinthera.2005.02.009_bib15","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.4049\/jimmunol.169.3.1535","article-title":"Activation of toll-like receptor 2 in acne triggers inflammatory cytokine responses","volume":"169","author":"Kim","year":"2002","journal-title":"J Immunol"}],"container-title":["Clinical Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291805000287?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291805000287?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,27]],"date-time":"2019-01-27T13:22:20Z","timestamp":1548595340000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0149291805000287"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,2]]},"references-count":15,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2005,2]]}},"alternative-id":["S0149291805000287"],"URL":"https:\/\/doi.org\/10.1016\/j.clinthera.2005.02.009","relation":{},"ISSN":["0149-2918"],"issn-type":[{"value":"0149-2918","type":"print"}],"subject":[],"published":{"date-parts":[[2005,2]]}}}